Fulgent Genetics, Inc. Q1 Loss Decreases, beats estimates

Fulgent Genetics, Inc. (FLGT) announced Loss for first quarter that decreased from the same period last year but beat the Street estimates.

The company's earnings totaled -$13.46 million, or -$0.45 per share. This compares with -$15.34 million, or -$0.52 per share, in last year's first quarter.

Excluding items, Fulgent Genetics, Inc. reported adjusted earnings of -$0.27 million or -$0.01 per share for the period.

Analysts on average had expected the company to earn -$0.32 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 2.5% to $64.49 million from $66.17 million last year.

Fulgent Genetics, Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$13.46 Mln. vs. -$15.34 Mln. last year.
-EPS (Q1): -$0.45 vs. -$0.52 last year.
-Revenue (Q1): $64.49 Mln vs. $66.17 Mln last year.

-Guidance:
Full year EPS guidance: Approx. $-1.05
Full year revenue guidance: Approx. $280 Mln

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com